Nxera
NXERA CONTEMPLATIVE TRAILS BLUE 1 8 K

Clinical Data & Presentations

Find our published papers on our clinical stage and marketed programs below

Clinical Data & Presentations

Filter

Search

1st April 2022

Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients Journal of Neurosurgery

View

1st February 2022

Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials The Lancet Neurology

View